Novartis AG (NVS) vs Roche Holding AG (RHHBY)
A side-by-side comparison of Novartis AG and Roche Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
NVS
Novartis AG
$140.98HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
RHHBY
Roche Holding AG
$52.11HealthcareDelayed quote: Oct 2, 2026, 3:40 PM EDT
Total return — NVS vs RHHBY
growth of $100 · dividends reinvested · last 10yNVS +209.2% (+12.0%/yr)RHHBY +131.6% (+8.8%/yr)NVS compounded faster over this window
NVS RHHBY
NVS vs RHHBY: by the numbers
- •RHHBY is the larger company ($332.18B vs $267.96B market cap).
- •NVS converts more revenue to profit (22.93% vs 20.33% net margin).
- •RHHBY grew revenue faster over the past five years (3.94% vs 1.53% CAGR).
- •NVS pays the higher dividend yield (3.38% vs 2.96%).
Metrics side by side
Valuation
| Metric | NVS | RHHBY |
|---|---|---|
| P/E ratio | 21.26 | N/A |
| Forward P/E | 16.02 | N/A |
| PEG ratio | 1.38 | N/A |
| P/S ratio | 4.82 | N/A |
| P/B ratio | 6.45 | 8.24 |
| EV / EBITDA | 13.85 | N/A |
| FCF yield | 5.90% | N/A |
Profitability
| Metric | NVS | RHHBY |
|---|---|---|
| Gross margin | 74.44% | 73.73% |
| Operating margin | 30.54% | 29.16% |
| Net margin | 22.93% | 20.33% |
| ROE | 30.71% | 38.06% |
| ROIC | 13.93% | 19.71% |
Dividends
| Metric | NVS | RHHBY |
|---|---|---|
| Dividend yield | 3.38% | 2.96% |
| Payout ratio | 71.50% | N/A |
Growth (annualized)
| Metric | NVS | RHHBY |
|---|---|---|
| Revenue CAGR (5Y) | 1.53% | 3.94% |
| EPS CAGR (5Y) | 15.42% | 1.54% |
| FCF CAGR (5Y) | 8.92% | 5.54% |
| Total return CAGR (5Y) | 16.96% | 5.74% |
Frequently asked
- Which has grown faster, NVS or RHHBY?
- Over the past five years, RHHBY grew revenue faster — NVS at a 1.53% CAGR versus RHHBY at 3.94%.
- Does NVS or RHHBY pay a bigger dividend?
- NVS yields 3.38% and RHHBY yields 2.96% based on trailing dividends and the latest price.
- Is NVS or RHHBY more profitable?
- NVS runs the higher net margin — NVS at 22.93% versus RHHBY at 20.33%.
- How have NVS and RHHBY total returns compared?
- Over the past 10 years, NVS delivered 11.99% and RHHBY delivered 8.71% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Novartis AG P/E ratioNovartis AG dividend yieldRoche Holding AG dividend yieldNovartis AG ROERoche Holding AG ROENovartis AG operating marginRoche Holding AG operating marginNovartis AG revenue growthRoche Holding AG revenue growthNovartis AG free cash flowRoche Holding AG free cash flow
Novartis AG & Roche Holding AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.